Associate Professor, Department of Pharmacology & Therapeutics
Bastien Castagner obtained a Ph.D. in Chemistry at Columbia University in New York in 2004. His postdoctoral years were spent at ETH Zürich from 2005 - 2008. From 2009 - 2014 he was a Group Leader in the Institute of Pharmaceutical Sciences at ETH Zürich. He joined the Department of Pharmacology & Therapeutics at McGill in 2014 and was promoted to the rank of Associate Professor in 2020.
Dr. Castagner’s research focuses on the design of small-molecules and natural product analogues as novel drug candidates. He is especially interested in the chemistry and biology of inositol phosphates and carbohydrates. His group has been involved in novel strategies to inactivate the toxins responsible for the pathogenesis of Clostridioides difficile. He is also interested in the human gut microbiota and how molecules can impact its composition and metabolism, for the benefit of the host (us!).